VALUE OF AMINOTRANSFERASES IN LIVER CIRRHOSIS

Aim: To ditermine values of ASAT and ALAT and their ratio in different stages of liver cirrhosis. Material and methods: A retrospective study was conducted, including patients with newly diagnosed liver cirrhosis from 01.01. 2017 to 31.12. 2021. Of all, 258 (71%) were men and 103 (29%) were women....

Full description

Bibliographic Details
Published in:	Journal of IMAB
Main Authors:	Miroslava Mihaylova, Strahil Strashilov, Pencho Tonchev
Format:	Article
Language:	English
Published:	Peytchinski Publishing 2024-10-01
Subjects:	aminotransferases liver child-pough meld na
Online Access:	https://www.journal-imab-bg.org/issues-2024/issue4/2024vol30-issue4-5824-5828.pdf

Similar Items

Thrombocytopenia in newly diagnosed cases of liver cirrhosis
by: Miroslava Mihaylova-Strashilova, et al.
Published: (2024-12-01)

Anemia in Newly Diagnosed Cases with Liver Cirrhosis
by: Mihaylova M., et al.
Published: (2025-03-01)

Relationship between Child-Pough score and late complications in hospital patients with liver cirrhosis
by: Miroslava Mihailova-Strashilova, et al.
Published: (2024-11-01)

SURGICAL RISK ASSESSMENT IN PATIENTS WITH LIVER CIRRHOSIS – A LITERATURE REVIEW
by: Elina Merashka
Published: (2025-01-01)

A comparative analysis between Model for End-stage Liver Disease score (MELD), Modified Model for End-stage Liver Disease score (MELD-Na), and Child–Pugh score (CPS) in predicting complications among cirrhosis patients
by: Anagha Ravinath Naik, et al.
Published: (2025-07-01)

Machine Learning for Short-Term Mortality in Acute Decompensation of Liver Cirrhosis: Better than MELD Score
by: Nermin Salkić, et al.
Published: (2024-05-01)

Analyzing prognosis and comparing predictive scoring systems for mortality of COVID-19 patients with liver cirrhosis: a multicenter retrospective study
by: Shou-Yen Chen, et al.
Published: (2024-11-01)

Comparison of Mortality Prediction Between the Model for End-Stage Liver Disease-3.0 (MELD-3.0) and the Model for End-Stage Liver Disease-Lactate (MELD-La) in Korean Patients with Liver Cirrhosis
by: Seung-Kang Yoo, et al.
Published: (2025-03-01)

Decompensated liver cirrhosis: assessment of complications and mortality in hospitalised patients
by: L. Cuko, et al.
Published: (2024-03-01)

Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis
by: Ayse L Mindikoglu, et al.
Published: (2020-02-01)

Correlations between the value of serum cholinesterase and Child-Pugh and Meld-Na scores in cirrhotic patients
by: George Stancu, et al.
Published: (2022-06-01)

Impact of sarcopenia on the survival of patients undergoing liver transplantation for decompensated liver cirrhosis
by: Da Zhou, et al.
Published: (2023-12-01)

Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy
by: Mo-Jong Kim, et al.
Published: (2023-01-01)

MELD–Na as a prognostic score for cirrhotic patients
by: Yousra Meguenni, et al.
Published: (2023-12-01)

Vitamin D Levels are Associated with Liver Disease Severity in Patients with Cirrhosis
by: Megan A. Rech, et al.
Published: (2017-05-01)

Levels of alanine aminotransferase and aspartate aminotransferase in coronavirus disease 2019 patients: a meta-analysis
by: LIU Weigao, et al.
Published: (2020-07-01)

以MELD 3.0为基础的模型在预测酒精性肝硬化患者生存预后中的价值
by: 钟臻蔚, et al.
Published: (2025-03-01)

Serum alanine aminotransferase/aspartate aminotransferase ratio is one of the best markers of insulin resistance in the Chinese population
by: Li Zhao, et al.
Published: (2017-10-01)

The Differences of T-Regulator Cells, Alanine Aminotransferase Serum and Aspartate Aminotranspherase Between Hepatitis B Chronic Patients with and without Liver Fibrosis
by: Yostila Derosa, et al.
Published: (2021-09-01)

The unwell patient with advanced chronic liver disease: when to use each score?
by: Oliver Moore, et al.
Published: (2025-07-01)

Value of Some Scoring Systems for the Prognosis of Rebleeding and In-Hospital Mortality in Liver Cirrhosis with Acute Variceal Bleeding
by: Duong Quang Huy, et al.
Published: (2023-03-01)

The Neurometabolic Function of the Dopamine–Aminotransferase System
by: Sergey A. Apryatin
Published: (2025-01-01)

Serum Lipid Profile as a Predictive Biomarker for Liver Cirrhosis Severity and its Association with CHILD PUGH and Model for End-Stage Liver Disease Scores
by: Nikhil Doshi, et al.
Published: (2025-09-01)

A Decline in Aminotransferase Activity Due to Lifestyle Modification in Children with NAFLD
by: Pawel Malecki, et al.
Published: (2021-03-01)

Investigating the Effect of Iron Chelation Therapy With Deferasirox on Liver Aminotransferases Levels in Transfusion-dependent β-thalassemia Patients
by: Shayan Pourkazem, et al.
Published: (2024-06-01)

Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases
by: Patrizia Burra, et al.
Published: (2025-01-01)

The Relationship Between Aspartate Aminotransferase To Alanine Aminotransferase Ratio And Metabolic Syndrome In Adolescents In Northeast China
by: Lin S, et al.
Published: (2019-11-01)

Correlation of Sarcopenia with Etiologies of Liver Cirrhosis and Its Association with Child-Pugh and MELD Scores
by: Navpreet Kaur Batth, et al.
Published: (2025-06-01)

Prognostic indicators and risk factors for the in-hospital mortality rate of patients with cirrhosis
by: Zahra Shokati Eshkiki, et al.
Published: (2024-07-01)

The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma
by: Wentao Zhu, et al.
Published: (2022-10-01)

Predictors for postoperative dysphagia in liver transplant recipients
by: Marian Isdahl, et al.
Published: (2024-08-01)

Liver inflammation activity in patients with autoimmune hepatitis with normal alanine aminotransferase and immunoglobulin G levels
by: Yun Chen, et al.
Published: (2024-06-01)

Development of an Electrochemical-Based Aspartate Aminotransferase Nanoparticle Ir-C Biosensor for Screening of Liver Diseases
by: Chung-Chiun Liu, et al.
Published: (2012-05-01)

Preoperative MELD-Na Score Predicts 30-day Post-operative Complications After Colorectal Resection for Malignancy
by: Adil Koyuncu, et al.
Published: (2023-02-01)

Aminotransferases activity on additional therapy in rheumatoid arthritis patients with liver disease.
by: Iryna Klymas, et al.
Published: (2024-03-01)

Unmasking hypoxia in Cirrhosis patients: Six-minute walk test as a screening tool for hepatopulmonary syndrome
by: Abhishek Singhai, et al.
Published: (2022-01-01)

AMINOTRANSFERASE ACTIVITY IN THE LIVER OF RAINBOW TROUT (ONCORHYNCHUS MYKISS) UNDER VIRAL INFECTION
by: L. Dragan, et al.
Published: (2015-10-01)

Asymptomatic elevation of serum aminotransferase activity: stages of diagnostic search
by: Yu. A. Tereshchenko, et al.
Published: (2014-07-01)

Association between Asia–Pacific body mass index classification and serum liver enzymes: alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase in healthy individuals
by: Epitagama Liyana Arachchige Navoda Navanjalee Dilhara, et al.
Published: (2023-08-01)

Investigation of Changes in Aspartate Aminotransferase and Alanine Aminotransferase in Serum and Saliva of Patients with Inflammatory Bowel Disease (IBD)
by: Mohammad Arbaghaei, et al.
Published: (2024-10-01)